Boston Run for the Warriors® Supports Wounded Service Members, Veterans and Families
American Society of Anesthesiologists (ASA)ASA and Hope For The Warriors® host 5K run/walk
ASA and Hope For The Warriors® host 5K run/walk
Orlando, FL (October 16, 2017)—Irving M. Pike, MD, FACG, a physician hospital executive and expert on endoscopic quality indicators, was elected by the membership as the 2017-2018 President of the American College of Gastroenterology (ACG), a national medical organization representing more than 14,000 clinical gastroenterologists and other specialists in digestive diseases. Dr. Pike officially took his position as President during the College’s Annual Scientific Meeting at the World Congress of Gastroenterology at ACG2017, held this week in Orlando. In this position, Dr. Pike will direct ACG’s programs which include continuing medical education in the clinical, scientific and patient-related skills of gastroenterology, activities involving national and state medical affairs, health policy issues, and clinical investigation.
Orlando, FL (October 16, 2017) – More than 5,000 gastroenterologists and other health care professionals from nearly 70 countries around the world will convene at the Orange County Convention Center in Orlando, FL for the World Congress of Gastroenterology at ACG2017 Annual Scientific Meeting and Postgraduate Course (WCOG at ACG2017) to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.
In addition to the major talks and awards at ATA's 87th Annual Meeting, a variety of scientific and clinical presentations will be accessible to attendees in the form of posters and oral abstracts.
In addition to the major speeches and awards at the ATA's 87th Annual Meeting, a variety of smaller presentations will be accessible to attendees in the form of posters and oral abstracts.
The Case Center for Synchrotron Biosciences has been awarded second prize in the 2017 Sharing Research Resources Award by the American Association of Medical Colleges. According to the AAMC, “award winners demonstrate successful sharing of research resources between institutions and campuses, including medical schools, teaching hospitals, and other academic institutions.”
Orlando, FL (October 13, 2017) – The American College of Gastroenterology (ACG) announces the winners of the 2017 SCOPY Awards (Service Award for Colorectal Cancer Outreach, Prevention and Year-Round Excellence) to recognize the achievements of ACG members in their community engagement, education and awareness efforts for colorectal cancer prevention.
Stony Brook Medicine's eighth annual Meeting of the Minds: Stroke Symposium will be held on Friday, October 20, at the Charles B. Wang Center from 8 am to 12:30 pm.
Faculty members speak at the Congress of Neurological Surgeons (CNS) Meeting in Boston.
The Icahn School of Medicine at Mount Sinai is preparing to host the 6th annual SINAInnovations conference, whose theme this year is “Cancer.”
The Association of American Cancer Institutes will host about two dozen new cancer center directors at its annual meeting in Washington, DC, October 15 - 17.
Preliminary findings presented at this year’s American Society for Radiation Oncology Annual Meeting suggest a genetic test for HPV16 in the blood could be useful to help assess risk for patients, and could help identify patients suitable for lower treatment doses.
The 87th Annual Meeting of the American Thyroid Association (ATA), taking place October 18‒22, 2017, in Victoria, British Columbia, will offer informative symposia presented by pioneering investigators and key opinion leaders
Two-day national event in Louisville, Kentucky Oct. 9-10 hosted by The Root Cause Coalition focusing on “how” communities and organizations can address basic needs to improve community and individual health and well-being.
A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival outcomes. The analysis of more than 9,000 prostate tumors also found evidence that PD-L2, not PD-L1, may provide a key route for targeted therapies, such as immunotherapy, to slow disease progression.
Radiation therapy following mastectomy for intermediate-stage, high-risk breast cancer can be shortened from five to three weeks while maintaining tumor control rates in the breast and surrounding region that are equivalent to conventional treatment, according to research presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized non-small cell lung cancer (NSCLC) and afford physicians additional lead time to personalize treatment for recurrent disease.
The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place October 29 – November 2 in Denver, Colorado.
A pilot program that uses big data to predict which lung cancer patients will require a trip to an emergency department (ED) successfully anticipated a third of all ED visits over a two week trial period, and was further able to identify which patients were at high risk and low risk of requiring such care. The predictive model was designed by researchers at the Perelman School of Medicine at the University of Pennsylvania with the eventual goal of developing a tool for early intervention that will help patients avoid ED visits.
A new study finds that Medicaid expansion enacted as part of the Patient Protection and Affordable Care Act (ACA) improved coverage for care for cancer patients receiving radiation therapy and potentially decreased health care disparities.
For certain patients with oropharyngeal cancer caused by the human papilloma virus (HPV), an aggressive reduction of radiation therapy after surgery may provide excellent cancer control while simultaneously reducing post-treatment side effects, improving quality of life and lowering treatment costs, according to research presented today at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO).
In a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plus chemotherapy when compared with pelvic radiation therapy.
A new survey finds breast cancer patients’ actual radiation therapy experiences largely exceeded their expectations.
Psychological distress has long been associated with negative health outcomes for cancer patients, though specific reasons remain unclear.
A new study of patients at an urban cancer center points to a potentially serious problem that may limit the impact of clinical cancer care—undiagnosed depression.
Long-term results of a phase III clinical trial indicate that survival rates for patients receiving chemoradiation for unresectable, locally advanced non-small cell lung cancer (NSCLC) may be more than twice as high as previous estimates.
Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial reported today at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body’s immune system to attack the cancer.
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) each than following two, 9-Gy fractions of high-dose-rate (HDR) brachytherapy, but neither overall survival nor severe treatment-related side effects differed between the treatment groups.
NCCN 12th Annual Congress: Hematologic Malignancies™ will be held October 6 – 7, 2017 in San Francisco, California, and features a new Nursing Forum.
The American Society for Radiation Oncology (ASTRO) is awarding $275,000 in research awards to four early-career scientists as part of the Society’s efforts to retain and foster the intellectual research talent currently entering the field of radiation oncology.
ISPOR announced plenary sessions and speakers for its 20th Annual European Congress that will be held 4-8 November 2017 in Glasgow, Scotland, UK. The congress will center on the theme, “The Evolution of Value in Health Care.”
ISPOR held its second plenary session, The Voice of the Patient, at its 6th Latin America Conference today focusing on how countries in the region can better incorporate the patient voice in the health care decision-making process.
ISPOR held the first plenary session of its 6th Latin America Conference today exploring the challenges and opportunities inherent in the move many of the region’s countries are taking toward universal health care coverage.
ANESTHESIOLOGY® 2017, the annual meeting of the American Society of Anesthesiologists (ASA), returns Oct. 21-25 to the city where modern anesthesia was born, Boston.
Today, at the 2017 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, Dr. Ikjae Lee, Assistant Professor of Neurology at the University of Alabama at Birmingham, was honored as the Best Abstract Award Winner for his research, Gender and Quality of Life In Myasthenia Gravis Patients From The Myasthenia Gravis Foundation of America Registry.
The press program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO) will feature advances in cancer research, including reports from phase II and III clinical trials. Studies that examine innovative treatments, such as immunotherapy, mental health influences on cancer outcomes and optimal radiation dosing and sequencing, will also be presented at the largest meeting for the field of radiation oncology.
The immunotherapy drug nivolumab is safer and more effective than ipilimumab—the current standard of care—in treating patients with resected stage III and stage IV melanoma.
“Biosimilars: To Switch or Not to Switch?” will be the focus of this year’s Great Debate at the 2017 ACR/ARHP Annual Meeting in San Diego. The debate is scheduled for 2:30 p.m. on Nov. 5 and will feature the perspectives of Dr. Jonathan Kay and Dr. Roy Fleischmann.
University of Washington researchers are developing a smartphone app that is capable of objectively detecting concussion and other traumatic brain injuries in the field, which could provide a new level of screening for athletes or accident victims.
A clinical trial testing the immunotherapy drug pembrolizumab shows the drug to be well tolerated among patients who have carcinoid or pancreatic neuroendocrine tumors. That’s according to investigators at Rutgers Cancer Institute of New Jersey and others. The work is being presented at the European Society for Medical Oncology 2017 Congress next week in Madrid.
ISPOR, the leading professional society for health economics and outcomes research, announced confirmation of the scientific sessions for its upcoming 6th Latin America Conference scheduled for 15-17 September 2017 in São Paulo, Brazil.
The latest research on patient preferences, quality-of-life, ear health, thyroidectomy, and other topics related to the specialty of otolaryngology will be presented in Chicago, IL, September 10-13, during the AAO-HNSF 2017 Annual Meeting & OTO Experience. The 2017 Annual Meeting includes hundreds of research presentations. All abstracts to be presented are now available online.
The American Society for Radiation Oncology (ASTRO) has selected 43 recipients to be presented with one of its 2017 Annual Meeting Abstract Awards.
Workers in the hardmetal industry are not at increased risk for lung cancer or any of 63 other potential causes of death, concluded the largest and most definitive study on this population to date. The study of more than 32,000 workers in five countries was performed after smaller French and Swedish studies indicated that tungsten carbide with a cobalt binder – the primary ingredients in hardmetal – may be linked to an increased risk of lung cancer.
Heat therapy may be a promising treatment against cancer and autoimmune diseases. University of Kentucky researchers exposed colorectal cancer cells and T-cells to temperatures high and low temperatures to observe the effects on cellular energy production.They will present their findings at the Physiological Bioenergetics: Mitochondria from Bench to Bedside conference in San Diego.
Improved muscle performance starts with better mitochondrial function. Older adults who are overweight may improve their muscle function with a weight loss program that combines exercise and calorie reduction, according to researchers from Florida Hospital, in Orlando, Fla., who present their findings today at the American Physiological Society’s Physiological Bioenergetics: Mitochondria from Bench to Bedside conference in San Diego.
In humans, going just minutes without oxygen—such as during a heart attack or stroke—can cause devastating damage to the heart. Researchers looking to freshwater turtles to understand the mechanisms that protect them from heart damage after long hibernation periods will present their findings at the Physiological Bioenergetics: Mitochondria from Bench to Bedside conference in San Diego.
Leading researchers will discuss advances in understanding the role of mitochondria in health and disease and the use of the “powerhouse of the cell” as a clinical diagnostic tool during the “Translating the Mitochondria—Taking It to the Clinic” symposium at the American Physiological Society’s Physiological Bioenergetics: Mitochondria from Bench to Bedside conference.
A new app from University of Washington researchers could lead to earlier detection of pancreatic cancer -- simply by snapping a smartphone selfie. The disease kills 90 percent of patients within five years, in part because no telltale symptoms or non-invasive screening tools exist to catch a tumor before it spreads.